ArticleJournal of molecular histology2026
Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease.
Jiawei Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.